SensoDetect is accelerating its expansion in China with new partnerships, groundbreaking hardware and strategic growth initiatives. Read more.
Senzime announces that the second tranche of the private placement of SEK 110 million has been fully subscribed. Read more.
Bioretec has appointed Rene Eve as Director of Operations for Bioretec Ltd. Read more.
Xbrane Biopharma publishes information documents regarding the admission to trading of the newly issued shares in Xbrane. Read more.
Dynavox Group An agreement is entered into to acquire RehaMedia in Germany. Read more.
Getinge and Zimmer Biomet enters into a strategic partnership within the ASC sector. Read more.
Navamedic ASA updates key information related to the rights issue. Read more.
Yesterday was the last day for trading unit rights in Pila Pharmas Rights issue of units. Read more.
ProstaLund decides, subject to the subsequent approval of the general meeting, to apply for delisting from Nasdaq First North Growth Market. Read more.
Xbrane Biopharma publishes exemption documents regarding admission to trading of the newly issued shares in Xbrane. Read more.
Insider trading & whistleblowing
Invitations & presentations
Summons
Reports
Arjo XVI Episurf Ray Intelligence
The latest from BioStock
» Merck gears up in lung diseases with giant acquisition
» AstraZeneca strengthens gene therapy portfolio with deals worth up to $825 million
» Modus Therapeutics CEO comments on latest milestone
» The new era of weight loss: Does GLP-1 live up to expectations?
» New announcement from Japan strengthens Medivir's patent portfolio
» Trump threatens 200 percent tariffs on pharmaceuticals